BANK VONTOBEL/PUT/ELI LILLY & CO/720/0.1/20.12.24 | Market Closed - Börse Stuttgart 02:49:06 2024-07-05 am EDT | ||
| 1.53 EUR | -5.56% |
|
| Current month | +15.91% | ||
| 1 month | -37.55% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 1.53 | -5.56% |
| 24-07-04 | 1.62 | +16.55% |
| 24-07-03 | 1.39 | +11.20% |
| 24-07-02 | 1.25 | -5.30% |
| 24-07-01 | 1.32 | 0.00% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 02:49 am EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VD21NE |
| ISIN | DE000VD21NE6 |
| Date issued | 2024-03-27 |
| Strike | 720 $ |
| Maturity | 2024-12-20 (168 Days) |
| Parity | 10 : 1 |
| Emission price | 4.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.29 € |
|---|---|
| Lowest since issue | 1.25 € |
| Spread | 0.02 € |
| Spread % | 1.55% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Warrants
- Warrant
